Published in Clin Dev Immunol on July 19, 2012
Extrahepatic manifestations of chronic hepatitis C virus infection. Ther Adv Infect Dis (2016) 0.96
Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia. PLoS One (2013) 0.91
Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy. Case Reports Immunol (2015) 0.85
CD81 and hepatitis C virus (HCV) infection. Viruses (2014) 0.84
Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection. Biomed Res Int (2014) 0.83
Genome-wide association study of hepatitis C virus- and cryoglobulin-related vasculitis. Genes Immun (2014) 0.81
New insights into HCV-related rheumatologic disorders: A review. J Adv Res (2016) 0.79
Antiviral therapy improves overall survival in hepatitis C virus-infected patients who develop diffuse large B-cell lymphoma. Int J Cancer (2016) 0.79
Hepatitis C infection in hemodialysis patients: A review. World J Hepatol (2015) 0.79
Hepatitis C virus-related mixed cryoglobulinemia: is genetics to blame? World J Gastroenterol (2013) 0.79
MicroRNA expression in hepatitis C virus-related malignancies: A brief review. World J Gastroenterol (2015) 0.79
Hepatitis C among Egyptian Patients Referred for Bone Marrow Examination: Seroprevalence and Analysis of Hematological Findings. Bone Marrow Res (2014) 0.77
Hepatitis C virus and non-Hodgkin's lymphomas: A minireview. J Adv Res (2016) 0.75
Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know? Ther Adv Hematol (2015) 0.75
Vasculitic syndromes in hepatitis C virus: A review. J Adv Res (2016) 0.75
Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients With Circulating Cryoglobulins. Medicine (Baltimore) (2015) 0.75
Hepatitis C Virus Infection in the Older Patient. Infect Dis Clin North Am (2017) 0.75
Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science (2005) 16.84
Binding of hepatitis C virus to CD81. Science (1998) 12.40
Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med (2002) 7.52
Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature (2007) 7.04
Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat Med (2009) 3.72
Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol (1992) 3.35
Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol (1994) 2.71
Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol (2003) 2.60
Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med (2002) 2.56
Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci U S A (2004) 2.30
Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis (2006) 2.24
Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism. Gastroenterology (2006) 1.93
Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol (2008) 1.91
Hepatitis C virus biology. Cell Death Differ (2003) 1.83
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci U S A (2005) 1.76
The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood (2001) 1.75
Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice. Hepatology (1998) 1.74
Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood (2003) 1.62
Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas. Leukemia (2004) 1.62
Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol (2005) 1.41
Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders. J Clin Oncol (2006) 1.30
Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood (1993) 1.29
Clinical and therapeutic implications of hepatitis C virus compartmentalization. Gastroenterology (2006) 1.22
Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol (2007) 1.22
Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development. Nat Rev Gastroenterol Hepatol (2010) 1.21
Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med (1996) 1.18
Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity? Blood (2004) 1.16
Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol (1998) 1.15
Hepatitis C virus lymphotropism: lessons from a decade of studies. Dig Liver Dis (2007) 1.14
T(14;18) translocation in chronic hepatitis C virus infection. Hepatology (2000) 1.08
Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection. Leukemia (2012) 1.06
Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection. Eur J Immunol (2004) 1.02
Non-Hodgkin's lymphoma: possible role of hepatitis C virus. JAMA (1994) 1.01
Persistent expression of the full genome of hepatitis C virus in B cells induces spontaneous development of B-cell lymphomas in vivo. Blood (2010) 1.01
Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C. Am J Med (2007) 1.00
Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood (1993) 0.99
Enhanced expression of lymphomagenesis-related genes in peripheral blood B cells of chronic hepatitis C patients. Clin Immunol (2010) 0.98
MicroRNA in HCV infection and liver cancer. Biochim Biophys Acta (2011) 0.98
Immunoglobulin mimicry by Hepatitis C Virus envelope protein E2. Virology (2005) 0.93
High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection. Am J Gastroenterol (2008) 0.93
HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations. Leukemia (2006) 0.92
Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fcγ receptors. Arthritis Rheum (2011) 0.92
Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process. Int J Cancer (2000) 0.92
Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy. Arthritis Rheum (2005) 0.91
Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role. Arch Virol (1997) 0.91
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation. Blood (2003) 0.91
Hepatitis C virus causes uncoupling of mitotic checkpoint and chromosomal polyploidy through the Rb pathway. J Virol (2009) 0.91
Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment. Hepatology (2006) 0.90
Hepatitis C virus and disrupted interferon signaling promote lymphoproliferation via type II CD95 and interleukins. Gastroenterology (2009) 0.90
Effect of hepatitis C virus core protein on the molecular profiling of human B lymphocytes. Mol Med (2006) 0.90
Monoclonal gammopathy in patients with chronic hepatitis C virus infection. Blood (1996) 0.89
Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection. Ann Intern Med (1998) 0.88
Lymphoproliferative disorders in chronic hepatitis C. J Viral Hepat (2004) 0.87
Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both? Autoimmun Rev (2008) 0.85
Elevated Serum Levels of Osteopontin in HCV-Associated Lymphoproliferative Disorders. Cancer Biol Ther (2005) 0.85
Hepatitis C virus, non-Hodgkin's lymphomas and hepatocellular carcinoma. Br J Cancer (1998) 0.85
Expression of hepatitis C virus core protein associated with malignant lymphoma in transgenic mice. Comp Immunol Microbiol Infect Dis (2003) 0.84
Hepatitis C virus core protein enhances B lymphocyte proliferation. Dig Liver Dis (2007) 0.84
Involvement of PI3K in HCV-related lymphoproliferative disorders. J Cell Physiol (2008) 0.84
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. Mod Rheumatol (2011) 0.84
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? Blood (2008) 0.82
Hepatitis C virus RNA in the bone marrow of patients with mixed cryoglobulinemia and in subjects with noncryoglobulinemic chronic hepatitis type C. J Infect Dis (1995) 0.80
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders. Oncol Rep (2006) 0.80
Detailed analysis of the E2-IgM complex in hepatitis C-related type II mixed cryoglobulinaemia. J Viral Hepat (2006) 0.79
Lack of preferential localization of tumoral mass in B-cell non-Hodgkin's lymphoma associated with hepatitis C virus infection. Blood (1997) 0.79
Lymphotropic virus infection of peripheral blood mononuclear cells in B-cell non-Hodgkin's lymphoma. Acta Haematol (1997) 0.78
High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-γ. J Rheumatol (2011) 0.78
Random aneuploidy in chronic hepatitis C patients. Cancer Genet Cytogenet (2008) 0.78
Association between persistent lymphatic infection by hepatitis C virus after antiviral treatment and mixed cryoglobulinemia. Blood (2008) 0.78
Can type C hepatitis infection be complicated by malignant lymphoma? Lancet (1995) 0.76
Locomotor primitives in newborn babies and their development. Science (2011) 3.30
Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med (2002) 2.56
Hepatitis C virus-related lymphoproliferative disorders: an overview. World J Gastroenterol (2007) 1.22
Liver-stage development of Plasmodium falciparum, in a humanized mouse model. J Infect Dis (2006) 1.21
Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease. Blood (2010) 1.21
Hepatitis C virus RNA localization in human carotid plaques. J Clin Virol (2009) 1.13
Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: an alternative mechanism of HBx-related pathogenesis. Proc Natl Acad Sci U S A (2002) 0.96
Genetic determinants in hepatitis C virus-associated mixed cryoglobulinemia: role of polymorphic variants of BAFF promoter and Fcγ receptors. Arthritis Rheum (2011) 0.92
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation. Blood (2003) 0.91
The hepatitis C virus infection as a systemic disease. Intern Emerg Med (2012) 0.91
Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia. PLoS One (2013) 0.91
Changes in the spinal segmental motor output for stepping during development from infant to adult. J Neurosci (2013) 0.90
Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment. Hepatology (2006) 0.90
HBV and HCV chronic infection: autoimmune manifestations and lymphoproliferation. Autoimmun Rev (2008) 0.87
Detection of bcl-2 rearrangement in mucosa-associated lymphoid tissue lymphomas from patients with hepatitis C virus infection. Haematologica (2004) 0.86
Developmentally regulated expression of the mouse homologues of the potassium channel encoding genes m-erg1, m-erg2 and m-erg3. Gene Expr Patterns (2003) 0.86
HCV patients, psychopathology and tryptophan metabolism: analysis of the effects of pegylated interferon plus ribavirin treatment. Dig Liver Dis (2007) 0.85
Involvement of PI3K in HCV-related lymphoproliferative disorders. J Cell Physiol (2008) 0.84
Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection. Expert Rev Clin Immunol (2015) 0.83
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia? Blood (2008) 0.82
Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact. J Transl Med (2012) 0.82
Detection of WA B cells in hepatitis C virus infection: a potential prognostic marker for cryoglobulinemic vasculitis and B cell malignancies. Arthritis Rheum (2010) 0.82
Interferon lambda 3 rs12979860 polymorphism in patients with haemophilia and HCV infection: a predictor of spontaneous viral clearance and sustained virological response. Thromb Haemost (2014) 0.80
Effect of chronic hepatitis C virus infection on inflammatory lipid mediators. Dig Liver Dis (2007) 0.79
Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab. Dig Liver Dis (2007) 0.78
Association between persistent lymphatic infection by hepatitis C virus after antiviral treatment and mixed cryoglobulinemia. Blood (2008) 0.78
Gene modulation associated with inhibition of liver regeneration in hepatitis B virus X transgenic mice. World J Gastroenterol (2008) 0.77
Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment. J Transl Med (2014) 0.76